Literature DB >> 24411284

The lethal clone in prostate cancer: redefining the index.

Christopher E Barbieri1, Francesca Demichelis2, Mark A Rubin3.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24411284     DOI: 10.1016/j.eururo.2013.12.052

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  10 in total

Review 1.  Current trends and new frontiers in focal therapy for localized prostate cancer.

Authors:  Melissa H Mendez; Daniel Y Joh; Rajan Gupta; Thomas J Polascik
Journal:  Curr Urol Rep       Date:  2015-06       Impact factor: 3.092

Review 2.  Does true Gleason pattern 3 merit its cancer descriptor?

Authors:  Saiful Miah; Hashim U Ahmed; Alex Freeman; Mark Emberton
Journal:  Nat Rev Urol       Date:  2016-08-17       Impact factor: 14.432

3.  SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling.

Authors:  Mirjam Blattner; Deli Liu; Brian D Robinson; Dennis Huang; Anton Poliakov; Dong Gao; Srilakshmi Nataraj; Lesa D Deonarine; Michael A Augello; Verena Sailer; Lalit Ponnala; Michael Ittmann; Arul M Chinnaiyan; Andrea Sboner; Yu Chen; Mark A Rubin; Christopher E Barbieri
Journal:  Cancer Cell       Date:  2017-03-13       Impact factor: 31.743

Review 4.  Active surveillance for low-risk prostate cancer.

Authors:  Laurence Klotz
Journal:  Curr Urol Rep       Date:  2015-04       Impact factor: 3.092

5.  SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression.

Authors:  Jinfang Zhang; Ming Chen; Yasheng Zhu; Xiangpeng Dai; Fabin Dang; Junming Ren; Shancheng Ren; Yulia V Shulga; Francisco Beca; Wenjian Gan; Fei Wu; Yu-Min Lin; Xiaobo Zhou; James A DeCaprio; Andrew H Beck; Kun Ping Lu; Jiaoti Huang; Cheryl Zhao; Yinghao Sun; Xu Gao; Pier Paolo Pandolfi; Wenyi Wei
Journal:  Dev Cell       Date:  2018-12-27       Impact factor: 12.270

Review 6.  The Genomics of Prostate Cancer: A Historic Perspective.

Authors:  Mark A Rubin; Francesca Demichelis
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

Review 7.  The evolving landscape of prostate cancer somatic mutations.

Authors:  Kellie Cotter; Mark A Rubin
Journal:  Prostate       Date:  2022-08       Impact factor: 4.012

Review 8.  Active surveillance and focal therapy for low-intermediate risk prostate cancer.

Authors:  Laurence Klotz
Journal:  Transl Androl Urol       Date:  2015-06

9.  Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer.

Authors:  Karine Lefort; Paola Ostano; Maurizia Mello-Grand; Valérie Calpini; Maria Scatolini; Antonella Farsetti; G Paolo Dotto; Giovanna Chiorino
Journal:  Oncotarget       Date:  2016-07-26

10.  An ex vivo Tissue Culture Model for the Assessment of Individualized Drug Responses in Prostate and Bladder Cancer.

Authors:  Arjanneke F van de Merbel; Geertje van der Horst; Maaike H van der Mark; Janneke I M van Uhm; Erik J van Gennep; Peter Kloen; Lijkele Beimers; Rob C M Pelger; Gabri van der Pluijm
Journal:  Front Oncol       Date:  2018-10-02       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.